Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Clinical trial NCT00968942 · COMPLETED
Trial details
- NCT number
- NCT00968942
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2009-10-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.